1. Home
  2. ARCB vs SPRY Comparison

ARCB vs SPRY Comparison

Compare ARCB & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCB
  • SPRY
  • Stock Information
  • Founded
  • ARCB 1923
  • SPRY 2015
  • Country
  • ARCB United States
  • SPRY United States
  • Employees
  • ARCB N/A
  • SPRY N/A
  • Industry
  • ARCB Trucking Freight/Courier Services
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARCB Industrials
  • SPRY Health Care
  • Exchange
  • ARCB Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • ARCB 1.7B
  • SPRY 1.8B
  • IPO Year
  • ARCB N/A
  • SPRY N/A
  • Fundamental
  • Price
  • ARCB $70.33
  • SPRY $10.03
  • Analyst Decision
  • ARCB Buy
  • SPRY Strong Buy
  • Analyst Count
  • ARCB 13
  • SPRY 5
  • Target Price
  • ARCB $92.67
  • SPRY $31.00
  • AVG Volume (30 Days)
  • ARCB 264.2K
  • SPRY 3.1M
  • Earning Date
  • ARCB 10-31-2025
  • SPRY 11-12-2025
  • Dividend Yield
  • ARCB 0.68%
  • SPRY N/A
  • EPS Growth
  • ARCB 27.88
  • SPRY N/A
  • EPS
  • ARCB 6.77
  • SPRY N/A
  • Revenue
  • ARCB $4,054,102,000.00
  • SPRY $112,339,000.00
  • Revenue This Year
  • ARCB N/A
  • SPRY N/A
  • Revenue Next Year
  • ARCB $5.21
  • SPRY $182.40
  • P/E Ratio
  • ARCB $10.38
  • SPRY N/A
  • Revenue Growth
  • ARCB N/A
  • SPRY 22367.80
  • 52 Week Low
  • ARCB $55.19
  • SPRY $9.79
  • 52 Week High
  • ARCB $123.26
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • ARCB 43.11
  • SPRY 25.69
  • Support Level
  • ARCB $69.93
  • SPRY $9.97
  • Resistance Level
  • ARCB $73.73
  • SPRY $10.78
  • Average True Range (ATR)
  • ARCB 2.58
  • SPRY 0.66
  • MACD
  • ARCB -0.16
  • SPRY -0.11
  • Stochastic Oscillator
  • ARCB 4.80
  • SPRY 5.70

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: